Combinations of LSD1 inhibitors for use in the treatment of solid tumors
申请人:ORYZON GENOMICS, S.A.
公开号:US10265279B2
公开(公告)日:2019-04-23
The instant invention relates to therapeutic combinations of LSD1 inhibitors and one or more other active pharmaceutical ingredient(s) or pharmaceutically acceptable salts thereof. The combinations are particularly useful for treating neoplastic diseases, such as cancer, particularly small cell lung cancer (SCLC).
KURBANOV, D.;PASTUSHENKO, E. V.;ZLOTSKIJ, S. S.;RAXMANKULOV, D. L., ZH. ORGAN. XIMII, 1985, 21, N 4, 899-902
作者:KURBANOV, D.、PASTUSHENKO, E. V.、ZLOTSKIJ, S. S.、RAXMANKULOV, D. L.
DOI:——
日期:——
COMBINATIONS OF LSD1 INHIBITORS FOR USE IN THE TREATMENT OF SOLID TUMORS
申请人:HOFFMANN-LA ROCHE INC.
公开号:US20170281567A1
公开(公告)日:2017-10-05
The instant invention relates to therapeutic combinations of LSD1 inhibitors and one or more other active pharmaceutical ingredient(s) or pharmaceutically acceptable salts thereof. The combinations are particularly useful for treating neoplastic diseases, such as cancer, particularly small cell lung cancer (SCLC).
Kurbanov, D.; Pastushenko, E. V.; Zlot-skii, S. S., Journal of Organic Chemistry USSR (English Translation), 1985, vol. 21, # 4, p. 817 - 820
作者:Kurbanov, D.、Pastushenko, E. V.、Zlot-skii, S. S.、Rakhmankulov, D. L: